Herbalife Earnings Call Transcripts
Fiscal Year 2025
-
Delivered strong Q4 and full-year 2025 growth, with net sales up 6.3% in Q4 and adjusted EBITDA margin expansion. Innovation, digital transformation, and a major partnership with Cristiano Ronaldo position the company for continued growth in 2026, with net sales and EBITDA guidance reflecting ongoing momentum.
-
Leadership is leveraging decades of distributor experience to drive global personalization and digital innovation, including the Protocol app and Link BioSciences acquisition. Financially, the focus is on stable growth, disciplined capital allocation, and significant debt reduction by 2028.
-
Q3 2025 saw a return to net sales growth globally and in North America, with strong cash flow, reduced leverage, and robust product innovation. Four of five regions posted sales growth, and new digital and personalized wellness initiatives are driving engagement and future subscription revenue.
-
The company is executing a digital transformation, leveraging acquisitions to build a personalized health and wellness platform. North America is showing signs of recovery, and new digital tools are energizing distributors and improving customer retention. Margin improvement, debt reduction, and a focus on shareholder value are central to the financial outlook.
-
Q2 2025 net sales were $1.3B, down 1.7% year-over-year but flat on a constant currency basis, with adjusted EBITDA exceeding guidance. Product innovation and digital transformation are driving momentum, especially in North America, and full-year guidance has been raised.
-
The event highlighted a stabilized business model with renewed distributor growth, strategic leadership changes, and a focus on personalized nutrition through recent acquisitions. Financial priorities include debt reduction and leveraging AI to enhance distributor performance and operational efficiency.
-
Q1 2025 saw net sales of $1.2B, down 3.4% YoY but up 1.4% in constant currency, with adjusted EBITDA of $165M exceeding guidance. Strategic acquisitions and digital initiatives are set to drive future growth, while FX and China remain key uncertainties.
Fiscal Year 2024
-
Leadership transition announced with strong Q4 and full-year results, including net sales and EBITDA growth on a constant currency basis. Distributor metrics improved, debt reduced, and 2025 guidance projects continued growth despite FX headwinds.
-
Direct-selling resilience is driven by empowering entrepreneurial distributors, globalizing best practices, and leveraging innovative models like Nutrition Clubs. Strategic leadership changes and a focus on debt reduction are expected to support future growth and shareholder value.
-
Q3 2024 net sales were $1.2B, flat in constant currency, with Adjusted EBITDA of $167M exceeding guidance. Distributor recruitment rose 14% year-over-year, and strong cash flow enabled $85M in debt repayment, reducing leverage to 3.3x.
-
Leadership changes and restructuring have driven cost savings and stabilized sales, with new distributor programs and pricing models targeting growth in key regions. Financial guidance was updated to reflect higher EBITDA and lower revenue, while debt reduction and margin expansion remain priorities.
-
Q2 Adjusted EBITDA and margin reached seven-quarter highs, despite a 2.5% sales decline due to FX headwinds. Distributor recruiting reversed a 12-quarter decline, and new training initiatives are underway. Debt reduction remains a top priority, with $1 billion targeted over 4–5 years.
-
Recent executive changes and organizational restructuring have positioned the company for growth, with a focus on expanding distributor networks, leveraging nutrition clubs, and advancing technology integration. Financial strategy centers on debt reduction, while cautious exploration of GLP-1 opportunities and data-driven initiatives support long-term value creation.